JanOne (JAN) Stock Price, News & Analysis

Company Overview

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Key Stats

• Today's Range: N/A
• 50-Day Range: $1.90 to $3.49
• 52-Week Range: N/A
• Volume: 139,500 shs
• Average Volume: 229,417 shs
• Market Capitalization: $20.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JAN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of JanOne own?

Based on aggregate information from My MarketBeat watchlists, some other companies that JanOne investors own include Meta Platforms (META), NVIDIA (NVDA), Teradyne (TER), Salesforce (CRM), DraftKings (DKNG), fuboTV (FUBO) and Marathon Digital (MARA).

Company Calendar

• Today: 10/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:JAN
• CIK: 862861
• Web: www.janone.com
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: 2019

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.81 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -359.71%
• Return on Assets: -70.26%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.15
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: $39.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.67) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,980,000
• Free Float: 8,707,000
• Market Cap: $20.03 million
• Optionable: Not Optionable
• Beta: 2.16